Results 1 to 10 of about 1,544 (167)

Outcomes of immune checkpoint inhibitor rechallenge in advanced urothelial carcinoma: results from a global real-world evidence study. [PDF]

ESMO Open
Maiorano BA, Cigliola A, Tateo V, Mercinelli C, Pastorino GL, Dizman N, Ebrahimi H, Pal SK, Gupta S, Grivas P, Kamat AM, Spiess PE, Agarwal N, Necchi A.   +13 more
europepmc   +1 more source

Dysregulated levels of proangiogenic proteins in the placentas of children with autism spectrum disorder and attention-deficit hyperactivity disorder. [PDF]

Front Med (Lausanne)
Celis C, Troncoso F, López E, Escudero-Guevara E, Acurio J, Escudero C.   +5 more
europepmc   +1 more source

Results from a prospective registry of ¹⁸F-Fluciclovine PET/CT use in prostate cancer management: a cautionary lesson for implementation of PSMA PET. [PDF]

Am J Nucl Med Mol Imaging
Blinka S, Wong RL, Holt SK, Lo E, Cheng HH, Conrad N, Loesch H, Toulouse AE, Lai M, Hsieh AC, Grivas P, Yezefski T, Wright JL, Schweizer MT, Montgomery RB, Chen DL, Zeng J, Lin DW, Yu EY.   +18 more
europepmc   +1 more source

Correspondence on "Deficient DNA mismatch repair and Nectin-4 expression in upper tract urothelial carcinoma (UTUC)". [PDF]

J Cancer Res Clin Oncol
Peker P.
europepmc   +1 more source

Choreographing Well-Being: The Predictive Role of Self-Compassion on Life Satisfaction-A Therapeutic-Based Art Pedagogy Perspective in Recreational Dance. [PDF]

Sports (Basel)
Zafeiroudi A, Karagiorgos T, Tsartsapakis I, Grivas GV, Kouthouris C, Goulimaris D.   +5 more
europepmc   +1 more source

A mixed-method analysis of oncologist-patient communications about immune checkpoint inhibitors (COACH). [PDF]

Oncologist
Chen W, Majovski J, Bhatia S, Chan A, Grivas P, Lee S, Shah S, Thompson JA, Tykodi SS, Veatch JR, Schapira L, Hall ET.   +11 more
europepmc   +1 more source

Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies. [PDF]

Cancer Res Commun
Lee HJ, Gulati R, Sayar E, Patel RA, Itagi P, Richards HM, Persse T, Arora S, Coleman I, Adil M, Schuster SL, Shokri F, Wright JL, Yu EY, True LD, Chambers M, Hawley JE, Cheng HH, Schweizer MT, Grivas P, Nelson PS, Montgomery RB, Hsieh AC, Vakar-Lopez F, Morrissey C, Lam HM, Ha G, Tretiakova MS, Haffner MC, Raychaudhuri R.   +29 more
europepmc   +1 more source

Endoscopic treatment modalities for the management of gastroparesis: a critical review. [PDF]

Ann Gastroenterol
Ziogas DI, Manolakis A, Argyriou K, Papanikolaou IS, Grivas E, Kapsoritakis A.   +5 more
europepmc   +1 more source

The Contribution of the Double Rib Contour Sign and the Rib Index to the Study of Scoliogeny, Thoracic Deformity, Progression, Outcome of Treatments and Costoplasty for Idiopathic Scoliosis. [PDF]

Healthcare (Basel)
Grivas TB, Christodoulou AG, Christodoulou EA, Katzouraki G, Lykissas MG, Papagelopoulos PJ, Papadopoulos EC, Papastefanou S, Sekouris N, Soucacos PN, Soultanis KC, Vasiliadis E.   +11 more
europepmc   +1 more source

A plain language summary of the TROPiCS-04 study: sacituzumab govitecan use after platinum-based chemotherapy and immunotherapy in people with locally advanced or metastatic cancer of the bladder, urethra, or upper urinary tract. [PDF]

Future Oncol
Powles T, Tagawa ST, Vulsteke C, Gross-Goupil M, Park SH, Necchi A, De Santis M, Duran I, Morales-Barrera R, Guo J, Sternberg CN, Bellmunt J, Goebell PJ, Kovalenko M, Boateng F, Sierecki M, Wang L, Sima CS, Waldes J, Bangs R, Loriot Y, Grivas P.   +21 more
europepmc   +1 more source